JMKX-003561

N/A

Report date: 2024/02/23 16:26:21
NME

Base Information

Drug NameJMKX-003561
Drug Alias NameJMKX-003561
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRenal fibrosisNephrosisPulmonary Fibrosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangxi Jemincare Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Hangyu Pharmaceutical Co LtdJiangxi Jemincare Group Co Ltd
Inactive CompaniesN/A
Active IndicationsRenal fibrosisNephrosisPulmonary Fibrosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A